MONOCLONAL ANTIBODIES SPECIFIC FOR FIBROBLAST GROWTH FACTOR RECEPTOR 4 (FGFR4)AND METHODS OF THEIR USE
European Patent
24182233.7
Filed on 2024-06-14
24182233.7
Filed on 2024-06-14
MONOCLONAL ANTIBODIES SPECIFIC FOR FIBROBLAST GROWTH FACTOR RECEPTOR 4 (FGFR4)AND METHODS OF THEIR USE
United Kingdom
16778536.9
Filed on 2016-09-19
16778536.9
Filed on 2016-09-19
MONOCLONAL ANTIBODIES SPECIFIC FOR FIBROBLAST GROWTH FACTOR RECEPTOR 4 (FGFR4)AND METHODS OF THEIR USE
Germany
16778536.9
Filed on 2016-09-19
16778536.9
Filed on 2016-09-19
MONOCLONAL ANTIBODIES SPECIFIC FOR FIBROBLAST GROWTH FACTOR RECEPTOR 4 (FGFR4)AND METHODS OF THEIR USE
France
16778536.9
Filed on 2016-09-19
16778536.9
Filed on 2016-09-19
Chimeric Antigen Receptors Targeting CD-19
South Korea
2024-7016401
Filed on 2024-05-17
2024-7016401
Filed on 2024-05-17
METHODS OF PREPARING AN ISOLATED POPULATION OF DENDRITIC CELLS AND METHODS OF TREATING CANCER USING SAME
US Application 18/623,529
Filed on 2024-04-01
Filed on 2024-04-01
HIGH AFFINITY MONOCLONAL ANTIBODIES TARGETING GLYPICAN-2 AND USES THEREOF
US Application 18/661,979
Filed on 2024-05-13
Filed on 2024-05-13
SINGLE DOMAIN ANTIBODIES TARGETING THE S2 SUBUNIT OF SARS-COV-2 SPIKE PROTEIN
US Application 18/704,211
Filed on 2024-04-24
Filed on 2024-04-24
Chimeric Antigen Receptors Containing Glypican 2 Binding Domains
China
202080052372.2
Filed on 2020-07-17
202080052372.2
Filed on 2020-07-17
HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS
Belarus
202091335
Filed on 2020-06-26
202091335
Filed on 2020-06-26